Regulators Deny Human Trials For Elon's Brain Chip

The United States Food and Drug Administration (FDA) has rejected Elon Musk’s proposal for Neuralink to start human trials with its brain chip.


According to Reuters, on Thursday current and former employees reported that the FDA rejected the application in early 2022. The company was founded in 2016, but the proposal that was taken to the FDA in 2022 was the first time that the company had proposed its chip for human trial...

less than 50%

[link to www.oann.com (secure)]